Stock

UK’s CMA may accept Synopsys/Ansys deal remedies

Investing.com — The UK’s Competition and Markets Authority (CMA) said it may accept the remedies offered by Synopsys (NASDAQ:SNPS) and Ansys (NASDAQ:ANSS). The agency now has until until March 5, 2025 to make an official decision. The undertakings, offered by both companies at the end of last year on December 31, include the divestment of certain product lines.

Specifically, Ansys has proposed to divest its product for power consumption analysis of digital chips. On the other hand, Synopsys has offered to divest its Optical Solutions Group. The CMA has stated that there are reasonable grounds to believe that these undertakings might be accepted.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

This post appeared first on investing.com

Related posts
Stock

China Vanke’s CEO, chairman resign amid growing liquidity worries

(Reuters) – Property developer China Vanke said on Monday its chairman Yu Liang and CEO Zhu Jiusheng had resigned, amid growing concerns…
Stock

UMG shares rally after new multi-year pact with Spotify

Investing.com — Universal Music Group (AS:UMG) and Spotify (NYSE:SPOT) have announced a new multi-year deal for recorded music and publishing, the companies…
Stock

British Land stock drops following stake sale

Investing.com — Shares of British Land (LSE:LON:BLND) fell 1.5% after the company announced the sale of a 50% stake in Broadgate REIT,…